Tumor-derived death receptor 6 modulates dendritic cell development

Cancer Immunology, Immunotherapy

Volumn 57, Issue 6, 2008, Pages 777-787

  DeRosa, David C ^a   Ryan, Paul J ^a   Okragly, Angela ^a   Witcher, Derrick R ^a   Benschop, Robert J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Death receptor 6; Dendritic cells; Matrix metalloproteinase 14; Tolerance; Tumor immunity

Indexed keywords

ANTIGEN; CYTOKINE; DEATH RECEPTOR; DEATH RECEPTOR 6; GAMMA INTERFERON; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE 14; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; TUMOR CELL LINE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELL MEMBRANE; DENDRITIC CELLS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1BETA; LYMPHOCYTES; MATRIX METALLOPROTEINASE 14; MICE; MONOCYTES; PHENOTYPE; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 43349104738     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0413-1     Document Type: Article

References (43)

1. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-252
2. Pulendran B, Palucka K, Banchereau J (2001) Sensing pathogens and tuning immune responses. Science 293:253-256
3. Dunn GP, Koebel CM, Schreiber RD (2006) Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6:836-848
4. Gajewski TF, Meng Y, Harlin H (2006) Immune suppression in the tumor microenvironment. J Immunother 29:233-240
5. Schuler G, Schuler-Thurner B, Steinman RM (2003) The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 15:138-147
6. Steinman RM, Nussenzweig MC (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 99:351-358
7. Esche C, Lokshin A, Shurin GV et al (1999) Tumor's other immune targets: dendritic cells. J Leukoc Biol 66:336-344
8. Aalamian M, Pirtskhalaishvili G, Nunez A et al (2001) Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells. Prostate 46:68-75
9. Katsenelson NS, Shurin GV, Bykovskaia SN et al (2001) Human small cell lung carcinoma and carcinoid tumor regulate dendritic cell maturation and function. Mod Pathol 14:40-45
10. Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487-501
11. Pan G, Bauer JH, Haridas V et al (1998) Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett 431:351-356
12. Liu J, Na S, Glasebrook A et al (2001) Enhanced CD4+ T cell proliferation and Th2 cytokine production in DR6-deficient mice. Immunity 15:23-34
13. Zhao H, Yan M, Wang H et al (2001) Impaired c-Jun amino terminal kinase activity and T cell differentiation in death receptor 6-deficient mice. J Exp Med 194:1441-1448
14. Schmidt CS, Liu J, Zhang T et al (2003) Enhanced B cell expansion, survival, and humoral responses by targeting death receptor 6. J Exp Med 197:51-62
15. Kasof GM, Lu JJ, Liu D et al (2001) Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB. Oncogene 20:7965-7975
16. Overall CM, Lopez-Otin C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657-672
17. Seiki M (2003) Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 194:1-11
18. Tam EM, Morrison CJ, Wu YI et al (2004) Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc Natl Acad Sci U S A 101:6917-6922
19. Sato H, Takino T, Okada Y et al (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65
20. Sounni NE, Devy L, Hajitou A et al (2002) MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. Faseb J 16:555-564
21. Chang CC, Wright A, Punnonen J (2000) Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation. J Immunol 165:3584-3591
22. O'Garra A (1998) Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275-283
23. de Jong EC, Smits HH, Kapsenberg ML (2005) Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol 26:289-307
24. Kapsenberg ML (2003) Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3:984-993
25. Rovere-Querini P, Capobianco A, Scaffidi P et al (2004) HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 5:825-830
26. Dumitriu IE, Baruah P, Valentinis B et al (2005) Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 174:7506-7515
27. Prechtel AT, Steinkasserer A (2007) CD83: an update on functions and prospects of the maturation marker of dendritic cells. Arch Dermatol Res 299:59-69
28. Laguens G, Coronato S, Laguens R et al (2002) Human regional lymph nodes draining cancer exhibit a profound dendritic cell depletion as comparing to those from patients without malignancies. Immunol Lett 84:159-162
29. Polak ME, Johnson P, Di Palma S et al (2005) Presence and maturity of dendritic cells in melanoma lymph node metastases. J Pathol 207:83-90
30. Cochran AJ, Huang RR, Lee J et al (2006) Tumour-induced immune modulation of sentinel lymph nodes. Nat Rev Immunol 6:659-670
31. Randolph GJ, Angeli V, Swartz MA (2005) Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 5:617-628
32. Ishigami S, Natsugoe S, Uenosono Y et al (2003) Infiltration of antitumor immunocytes into the sentinel node in gastric cancer. J Gastrointest Surg 7:735-739
33. Iyoda T, Shimoyama S, Liu K et al (2002) The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 195:1289-1302
34. Liu K, Iyoda T, Saternus M et al (2002) Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 196:1091-1097
35. Liyanage UK, Moore TT, Joo HG et al (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169:2756-2761
36. Ormandy LA, Hillemann T, Wedemeyer H et al (2005) Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 65:2457-2464
37. Larmonier N, Marron M, Zeng Y et al (2007) Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunol Immunother 56:48-59
38. Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345-352
39. Fisson S, Darrasse-Jeze G, Litvinova E et al (2003) Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med 198:737-746
40. Whiteside TL, Stanson J, Shurin MR et al (2004) Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells. J Immunol 173:1526-1534
41. Kim R, Emi M, Tanabe K (2005) Cancer cell immune escape and tumor progression by exploitation of anti-inflammatory and pro-inflammatory responses. Cancer Biol Ther 4:924-933
42. Allavena P, Piemonti L, Longoni D et al (1998) IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 28:359-369
43. Buelens C, Verhasselt V, De Groote D et al (1997) Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol 27:756-762